Aida Pharmaceuticals, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Aida Pharmaceuticals, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Aida Pharmaceuticals, Inc.. The Group's principal activity is to develop, manufacture and distribute of antibiotics, cardiovascular and anti cancer drugs primarily in Mainland China. It has a total of nine production lines for the manufacturing of antibiotics, cardiovascular and anti-tumor drugs in various forms, including injectable powder, injectable liquid, capsules, tablets and ointments. The new products under developments by the Group include 5-Deoxy-Fluorordine, Apoptotic Factor, Adefovir Dipivoxil Tablets, Methylcanthatidinimid and SYO2.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report